Pentavalent Market: Major Key Players, Application, Growth And Analysis, Forecast To 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Pentavalent Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $3.17 billion In 2028 At A CAGR Of 4.6% :

The pentavalent market size has grown steadily in recent years. It will grow from $2.53 billion in 2023 to $2.65 billion in 2024 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to global immunization initiatives, government vaccination programs, prevention of multiple diseases, public health awareness, international partnerships and funding.

The pentavalent market size is expected to see steady growth in the next few years. It will grow to $3.17 billion in 2028 at a compound annual growth rate (CAGR) of 4.6%. The growth in the forecast period can be attributed to continued global immunization efforts, expansion of vaccination programs, introduction in new geographies, research and development initiatives, collaborations for vaccine access. Major trends in the forecast period include global health initiatives and funding support, public awareness and education campaigns, government policies and regulatory frameworks, technological innovations in vaccine manufacturing.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=9104&type=smp

Pentavalent Market Major Segments
The pentavalent market covered in this report is segmented -

1) By Type: Sodium Stibogluconate, Meglumine Antimoniate
2) By Formulation Type: Lyophilized, Liquid
3) By Application: Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies

Key Driver - Pentavalent Market Surges With Increasing Diphtheria Incidence

The rising prevalence of diphtheria is expected to boost the growth of the pentavalent market going forward. Corynebacterium diphtheriae is a bacterium that causes the severe, extremely contagious disease known as diphtheria. Diphtheria causes severe difficulties with eating and breathing, as well as the possibility of skin ulcers. The pentavalent vaccine protects children from Diphtheria diseases by a pentavalent immunization in a 3-dose schedule, as a result, the rising prevalence of diphtheria increased the demand for pentavalent vaccines. For instance, in 2022, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, an unusually high number of reported cases of diphtheria were recorded through the International Health Regulations (IHR) reporting process, primarily in the months of June and August 2022. Seven nations have documented 144 instances of diphtheria, many of which were among asylum seekers. Among 144 patients, 97 (69%) were determined to be clinically compatible, 44 (31%) to be toxigenic diphtheria cases by laboratory confirmation, and 3 (2%) were suspected cases. Therefore, the rising prevalence of diphtheria is driving the growth of the pentavalent market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=9104&type=smp

Prominent Trend - Key Companies Drive Growth Through Product Innovation In The Pentavalent Sector

Product innovation has emerged as the key trend gaining popularity in the pentavalent market. Major companies operating in the pentavalent market are developing innovative products to strengthen their position in the market. For instance, in December 2022, Pfizer, a US-based pharmaceutical company, operating in the pentavalent vaccines market got approval from The United States Food and Drug Administration, a US-based federal agency of the Department of Health and Human Services, for Pfizer's Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents, indicated for the prevention of meningococcal disease in individuals aged10 to 25. The unique element of the MenABCWY vaccine is the combination of the components of two vaccines into one, helping protect against the meningococcal serogroups that cause the majority of invasive meningococcal diseases.

Pentavalent Market Players
Major companies operating in the pentavalent market report are Pfizer Inc., Merck & Co Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, LG Chem Ltd., GlaxoSmithKline plc, Shandong Xinhua Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, PT Bio Farma (Persero), Shantha Biotechnics Limited, Seqirus Holdings plc, Biological E. Limited, Serum Institute of India Private Limited, Indian Immunologicals Limited, Incepta Pharmaceuticals Limited, Shanghai Institute of Biological Products Co Ltd., Changchun Changsheng Biotechnology Co Ltd., Adimmune Corporation, AJ Vaccines, Albert David Limited, Biogenics Pvt Ltd., GreenSignal Bio Pharma Limited, PanGen Biotech Inc., Biomed Pvt Ltd., Maiden Pharmaceuticals Limited, Panacea Drugs Limited, Crucell N.V., Bharat Biotech International Limited, Vacsera Ltd., Vacunas Finlay S.A., Pasteur Institute of India, Zydus Cadila Healthcare Limited, EuBiologics Co Ltd.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/pentavalent-global-market-report

Largest And Fastest Growing Region In The Market
Asia-Pacific was the largest region in the pentavalent market in 2023. The regions covered in the pentavalent market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Pentavalent Market Report Structure
3. Pentavalent Market Trends And Strategies
4. Pentavalent Market - Macro Economic Scenario
5. Pentavalent Market Size And Growth
…..
27. Pentavalent Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.